| P50 | author | Daniel A Waschbusch | Q40016371 |
| | Anil Chacko | Q46534668 |
| | Greta M. Massetti | Q59211742 |
| | Elizabeth M Gnagy | Q109360751 |
| P2093 | author name string | Antara Majumdar | |
| | William E Pelham | |
| | Gregory A Fabiano | |
| | Martin T Hoffman | |
| | Kathryn S Walker | |
| | James Waxmonsky | |
| | Allison C Garefino | |
| | Briannon O'Connor | |
| | Frances W Arnold | |
| | Jessica A Robb | |
| | Jessica Verley | |
| | Lisa Burrows-MacLean | |
| | Michael R Cummings | |
| P2860 | cites work | NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses | Q28142796 |
| | National trends in the outpatient diagnosis and treatment of bipolar disorder in youth | Q28244462 |
| | Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder | Q28249894 |
| | Increased rates of bipolar disorder diagnoses among U.S. child, adolescent, and adult inpatients, 1996-2004 | Q28288705 |
| | A rating scale for mania: reliability, validity and sensitivity | Q29619299 |
| | Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment | Q32041795 |
| | Systematic chart review of the pharmacologic treatment of comorbid attention deficit hyperactivity disorder in youth with bipolar disorder | Q33814162 |
| | Long-term effects of stimulant medications on the brain: possible relevance to the treatment of attention deficit hyperactivity disorder | Q33944135 |
| | Prior stimulant treatment in adolescents with bipolar disorder: association with age at onset | Q33945162 |
| | Severity of bipolarity in hospitalized manic adolescents with history of stimulant or antidepressant treatment | Q33960349 |
| | Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults | Q34113187 |
| | Can stimulant rebound mimic pediatric bipolar disorder? | Q34128678 |
| | Discriminative validity of a parent version of the Young Mania Rating Scale | Q34157172 |
| | Clinical implications of pervasive manic symptoms in children | Q34203184 |
| | Comparing the diagnostic accuracy of six potential screening instruments for bipolar disorder in youths aged 5 to 17 years | Q34328688 |
| | Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial | Q34341755 |
| | The Mania Rating Scale: can it be used in children? A preliminary report | Q34382865 |
| | The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder | Q34529904 |
| | A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents | Q34568810 |
| | Practice parameter for the assessment and treatment of children and adolescents with depressive disorders | Q34720078 |
| | Clinical course of children and adolescents with bipolar spectrum disorders | Q34814593 |
| | Defining clinical phenotypes of juvenile mania | Q35075420 |
| | Methodological issues and controversies in clinical trials with child and adolescent patients with bipolar disorder: report of a consensus conference | Q35153322 |
| | Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: an evidence-based medicine review | Q35842028 |
| | Treatment-emergent mania in pediatric bipolar disorder: a retrospective case review | Q35909656 |
| | Treatment guidelines for children and adolescents with bipolar disorder | Q36052032 |
| | Pediatric bipolar disorder: a review of the past 10 years | Q36237083 |
| | Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents | Q36532942 |
| | Diagnostic and measurement issues in the assessment of pediatric bipolar disorder: implications for understanding mood disorder across the life cycle | Q36634409 |
| | Pharmacological interventions for bipolar youth: developmental considerations | Q36634438 |
| | Evidence-based psychosocial treatments for attention-deficit/hyperactivity disorder | Q37150122 |
| | Autism spectrum disorder scale scores in pediatric mood and anxiety disorders | Q37328159 |
| | Psychoeducational treatment for school-aged children with bipolar disorder | Q40275807 |
| | ADHD comorbidity findings from the MTA study: comparing comorbid subgroups | Q40723668 |
| | Young referred boys with DICA-P manic symptoms vs. two comparison groups | Q42622991 |
| | Bupropion sustained release in adolescents with comorbid attention-deficit/hyperactivity disorder and depression | Q43565910 |
| | Anxiety and depression symptoms and response to methylphenidate in children with attention-deficit hyperactivity disorder and tic disorder | Q43990359 |
| | Child- and family-focused cognitive-behavioral therapy for pediatric bipolar disorder: development and preliminary results | Q44239566 |
| | Specificity of facial expression labeling deficits in childhood psychopathology | Q44283903 |
| | A 12-week single-blind trial of quetiapine for the treatment of mood symptoms in adolescents at high risk for developing bipolar I disorder | Q44326251 |
| | Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial | Q44525396 |
| | Cognitive flexibility in phenotypes of pediatric bipolar disorder | Q44724707 |
| | Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. | Q45206307 |
| | A pilot study of antidepressant-induced mania in pediatric bipolar disorder: Characteristics, risk factors, and the serotonin transporter gene | Q46301946 |
| | A pilot controlled trial of topiramate for mania in children and adolescents with bipolar disorder | Q46503060 |
| | Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD. | Q46534553 |
| | Methylphenidate in the treatment of children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder | Q46874086 |
| | Olanzapine versus placebo in the treatment of adolescents with bipolar mania | Q46979845 |
| | Is there progression from irritability/dyscontrol to major depressive and manic symptoms? A retrospective community survey of parents of bipolar children | Q47450075 |
| | Different psychophysiological and behavioral responses elicited by frustration in pediatric bipolar disorder and severe mood dysregulation | Q48291022 |
| | DSM-IV mania symptoms in a prepubertal and early adolescent bipolar disorder phenotype compared to attention-deficit hyperactive and normal controls | Q48661982 |
| | Parental diagnoses in youth with narrow phenotype bipolar disorder or severe mood dysregulation. | Q51900932 |
| | Prevalence, clinical correlates, and longitudinal course of severe mood dysregulation in children. | Q51911176 |
| | Drug-induced disinhibition in psychiatrically hospitalized children. | Q51947616 |
| | The naturalistic course of pharmacologic treatment of children with maniclike symptoms: a systematic chart review. | Q51988680 |
| | Bipolar disorders in a community sample of older adolescents: prevalence, phenomenology, comorbidity, and course. | Q52017239 |
| | Children with a prepubertal and early adolescent bipolar disorder phenotype from pediatric versus psychiatric facilities. | Q52980019 |
| | Early symptoms of mania and the role of parental risk. | Q52997457 |
| | A practical measure of impairment: psychometric properties of the impairment rating scale in samples of children with attention deficit hyperactivity disorder and two school-based samples. | Q53006887 |
| | Manic symptoms in psychiatrically hospitalized children--what do they mean? | Q54057010 |
| | A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder. | Q54187614 |
| | A prospective follow-up study of pediatric bipolar disorder in boys with attention-deficit/hyperactivity disorder | Q57400313 |
| | Teacher ratings of DSM-III-R symptoms for the disruptive behavior disorders | Q68095990 |
| | Preliminary studies of the reliability and validity of the children's depression rating scale | Q71328354 |
| | Separate and combined effects of methylphenidate and behavior modification on boys with attention deficit-hyperactivity disorder in the classroom | Q72817065 |
| | Diagnostic characteristics of 93 cases of a prepubertal and early adolescent bipolar disorder phenotype by gender, puberty and comorbid attention deficit hyperactivity disorder | Q73125620 |
| | Stimulant treatment in young boys with symptoms suggesting childhood mania: a report from a longitudinal study | Q73125627 |
| | A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD | Q73256558 |
| | Factor structure of the Young Mania Rating Scale for use with youths ages 5 to 17 years | Q78434781 |
| | Earlier onset of bipolar disorder in children by antidepressants or stimulants? An hypothesis | Q79364006 |
| | Response and remission in adolescent mania: signal detection analyses of the young mania rating scale | Q80195808 |
| | A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania | Q82844588 |
| P433 | issue | 6 | |
| P921 | main subject | attention deficit hyperactivity disorder | Q181923 |
| | attention | Q6501338 |
| P304 | page(s) | 573-588 | |
| P577 | publication date | 2008-12-01 | |
| P1433 | published in | Journal of Child and Adolescent Psychopharmacology | Q15756086 |
| P1476 | title | The efficacy and tolerability of methylphenidate and behavior modification in children with attention-deficit/hyperactivity disorder and severe mood dysregulation | |
| P478 | volume | 18 | |